Welcome!
Home hospital group
Broker's Calls
Medical tourism weakness in Singapore could be temporary: Maybank
SINGAPORE (June 5): Maybank Kim Eng Research continues to rate Raffles Medical Group (RMG) at “buy” as Singapore’s leading integrated healthcare provider, with a “robust track record and exciting development plans” of two hospitals in China.
June 05, 2017
Broker's Calls
Growth is a given for this leading healthcare stock, but the risks are still aplenty
SINGAPORE (June 5): Maybank Kim Eng Research is maintaining its “hold” call on IHH Healthcare with a higher price target of RM6.17 ($2) from RM5.62 previously, highlighting the stock as a healthcare leader in the premium hospital segment with a strong
June 05, 2017